Huntington National Bank’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $101 | Hold |
1
| – | – | ﹤0.01% | 2603 |
|
|
2025
Q4 | $101 | Hold |
1
| – | – | ﹤0.01% | 2523 |
|
|
2025
Q3 | $101 | Sell |
1
-5
| -83% | -$491 | ﹤0.01% | 2614 |
|
|
2025
Q2 | $590 | Hold |
6
| – | – | ﹤0.01% | 2412 |
|
|
2025
Q1 | $556 | Buy |
6
+5
| +500% | +$461 | ﹤0.01% | 2449 |
|
|
2024
Q4 | $91 | Sell |
1
-27
| -96% | -$2.48K | ﹤0.01% | 2750 |
|
|
2024
Q3 | $2.7K | Hold |
28
| – | – | ﹤0.01% | 2165 |
|
|
2024
Q2 | $2.57K | Buy |
28
+27
| +2,700% | +$2.5K | ﹤0.01% | 2096 |
|
|
2024
Q1 | $92 | Sell |
1
-16
| -94% | -$1.5K | ﹤0.01% | 2529 |
|
|
2023
Q4 | $1.62K | Buy |
17
+16
| +1,600% | +$1.49K | ﹤0.01% | 2115 |
|
|
2023
Q3 | $93 | Sell |
1
-145
| -99% | -$13.4K | ﹤0.01% | 2422 |
|
|
2023
Q2 | $13.3K | Sell |
146
-1
| -0.7% | -$82 | ﹤0.01% | 1485 |
|
|
2023
Q1 | $10.8K | Sell |
147
-6
| -4% | -$519 | ﹤0.01% | 1504 |
|
|
2022
Q4 | $12.8K | Buy |
153
+3
| +2% | +$270 | ﹤0.01% | 1423 |
|
|
2022
Q3 | $15K | Hold |
150
| – | – | ﹤0.01% | 1393 |
|
|
2022
Q2 | $16K | Buy |
150
+76
| +103% | +$9.71K | ﹤0.01% | 1405 |
|
|
2022
Q1 | $13K | Sell |
74
-130
| -64% | -$19.4K | ﹤0.01% | 1493 |
|
|
2021
Q4 | $33K | Buy |
204
+72
| +55% | +$11.6K | ﹤0.01% | 1200 |
|
|
2021
Q3 | $20K | Sell |
132
-1
| -0.8% | -$208 | ﹤0.01% | 1254 |
|
|
2021
Q2 | $33K | Sell |
133
-28
| -17% | -$7.35K | ﹤0.01% | 1067 |
|
|
2021
Q1 | $43K | Hold |
161
| – | – | ﹤0.01% | 894 |
|
|
2020
Q4 | $47K | Hold |
161
| – | – | ﹤0.01% | 831 |
|
|
2020
Q3 | $38K | Sell |
161
-3
| -2% | -$682 | ﹤0.01% | 860 |
|
|
2020
Q2 | $33K | Hold |
164
| – | – | ﹤0.01% | 889 |
|
|
2020
Q1 | $30K | Hold |
164
| – | – | ﹤0.01% | 929 |
|
|
2019
Q4 | $27K | Hold |
164
| – | – | ﹤0.01% | 1141 |
|
|
2019
Q3 | $21K | Hold |
164
| – | – | ﹤0.01% | 1096 |
|
|
2019
Q2 | $20K | Buy |
+164
| New | +$19.5K | ﹤0.01% | 1139 |
|
|
2014
Q1 | – | Sell |
-30
| Closed | – | – | 1169 |
|
|
2013
Q4 | $0 | Hold |
30
| – | – | ﹤0.01% | 1710 |
|
|
2013
Q3 | $0 | Hold |
30
| – | – | ﹤0.01% | 1738 |
|
|
2013
Q2 | $0 | Buy |
+30
| New | +$344 | ﹤0.01% | 1724 |
|
Huntington National Bank's AMED Position: Q1 2026 in Review
Huntington National Bank held its Amedisys (AMED) position steady in Q1 2026 at 1 share worth $101. The position accounts for ﹤0.01% of the portfolio, ranked #2603.
Huntington National Bank first reported a position in AMED in Q2 2013 and has held it in 31 quarters since. The position peaked at $47K in Q4 2020. 1 fund tracked by Wall St. Rank holds AMED as of Q1 2026.
- Huntington National Bank held 1 share of Amedisys worth $101 as of Q1 2026.
- Huntington National Bank left its Amedisys share count unchanged in Q1 2026.
- Amedisys made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2603 holding.
- Huntington National Bank first reported a position in Amedisys in Q2 2013 and has held it in 31 quarters since.
- Huntington National Bank's Amedisys position peaked at $47K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Amedisys as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.